RN7SL502P

Across TCGA pan-cancer cohorts, RN7SL502P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SL502P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RN7SL502P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL502P is over-expressed in tumor, although a few such as LUAD and KICH show the opposite, repressed pattern.

KIRC, LUAD, and LIHC are the cancer types where RN7SL502P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL502P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	+0.129	.003	5	view →
LUAD	All	IV	−0.425	<.001	2	view →
LIHC	All	All	+0.052	.015	2	view →
CHOL	All	All	+0.274	.028	1	view →
KICH	Male	All	−0.091	.031	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RN7SL502P–KIRC

Open the KIRC breakdown →